Tirzepatide targets both GLP-1 and GIP receptors, producing average weight loss of 2022% in clinical trialsroughly 50% greater than semaglutide alone
This vitamin is important for energy and nerve health
Because the cost is assembled from separate parts: medication, the consult or membership layer, and the dispensing pathway
GLP-1 medications, specifically semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), work in part by acting on receptors in the brain that regulate hunger
Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M et al (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
In this article: What is semaglutide